Product
UCLM802
1 clinical trial
1 indication
Indication
Solid TumorClinical trial
Exploratory Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid TumorsStatus: Not yet recruiting, Estimated PCD: 2024-05-01